Patents by Inventor Maxime BESSIERES

Maxime BESSIERES has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11603380
    Abstract: The present invention concerns a compound having the following formula (I): as well as its use as a medicament, especially for its use for treating viral infections.
    Type: Grant
    Filed: April 23, 2019
    Date of Patent: March 14, 2023
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE D'ORLEANS, NEOVIRTECH
    Inventors: Luigi Agrofoglio, Vincent Roy, Coralie De Schutter, Maxime Bessieres, Franck Gallardo
  • Patent number: 11479571
    Abstract: The present invention relates to compounds comprising a benzimidazole scaffold, and the use of such compounds for the treatment of viral diseases. The invention also relates to pharmaceutical compositions comprising said compounds as an active ingredient. In particular the compounds of the invention comprising a benzimidazole scaffold are used for the treatment of filoviruses or retroviruses, and preferably for the treatment of Ebola virus or HIV virus.
    Type: Grant
    Filed: September 14, 2017
    Date of Patent: October 25, 2022
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE D'ORLEANS
    Inventors: Luigi Agrofoglio, Vincent Roy, Elzbieta Plebanek, Maxime Bessieres
  • Publication number: 20210292350
    Abstract: The present invention relates to compounds comprising a benzimidazole scaffold, and the use of such compounds for the treatment of viral diseases. The invention also relates to pharmaceutical compositions comprising said compounds as an active ingredient. In particular the compounds of the invention comprising a benzimidazole scaffold are used for the treatment of filoviruses or retroviruses, and preferably for the treatment of Ebola virus or HIV virus.
    Type: Application
    Filed: September 14, 2017
    Publication date: September 23, 2021
    Inventors: Luigi AGROFOGLIO, Vincent ROY, Elzbieta PLEBANEK, Maxime BESSIERES
  • Publication number: 20210079031
    Abstract: The present invention concerns a compound having the following formula (I): as well as its use as a medicament, especially for its use for treating viral infections.
    Type: Application
    Filed: April 23, 2019
    Publication date: March 18, 2021
    Inventors: Luigi AGROFOGLIO, Vincent ROY, Coralie DE SCHUTTER, Maxime BESSIERES, Franck GALLARDO